Protective effects of statins on the incidence of NAFLD-related decompensated cirrhosis in T2DM.
Szu-Yuan WuWan-Ming ChenMing-Feng ChiangHung-Chieh LoMing-Shun WuMing-Che LeeRuey-Shyang SoongPublished in: Liver international : official journal of the International Association for the Study of the Liver (2023)
The results revealed the protective effects of specific types of statins on DLC risk in patients with T2DM and indicated a dose-response relationship. Additional studies are warranted to understand the specific mechanisms of action of different types of statins and their effect on DLC risk in patients with T2DM.